Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Reported Basic Consolidated EPS Of $0.7559 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) for the period ended 2015-12-31 was $0.7559. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $0.7559.

EPS from continuing operations

Coming to basic EPS from continuing operations, Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) reported $0.7559 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $0.7559.

EPS contribution from parent

For the annual period ended 2015-12-31, Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) received basic EPS of $0.7559 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $0.7559.

Basic net EPS

For the annual period ended 2015-12-31, Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) reported basic net EPS of $0.76. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $0.76.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $0.7305. For the quarter ended 2015-12-31, consolidated diluted EPS was $0.7305.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $0.7305 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $0.7305.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $0.73. For the quarterly period ended 2015-12-31, net diluted EPS was $0.73.

Diluted EPS from parent

From the parent company, Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) received diluted EPS of $0.7305 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $0.7305.

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) posted net basic EPS reading of $0.76 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $0.76 was for the quarter ended 2015-12-31.

Net diluted EPS for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) for the annual period ended 2015-12-31 was $0.73. The company also reported net diluted EPS reading of $0.73 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 44.15 while for the quarter ended 2015-12-31 is 44.15.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 45.68 while for the quarter ended 2015-12-31 is 45.68.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 30 times, 1 visits today)